In biotherapeutics manufacturing, controlling size variants of therapeutic monoclonal antibodies (mAbs) is critical for ensuring product quality.
Falguni Patel
Advertisement
Falguni Patel is with Tanvex Biopharma USA, Inc. in San Diego, California.
Articles by Falguni Patel
Advertisement
Latest Updated Articles
Analysis of Therapeutic Monoclonal Antibodies Using a Platform Size Exclusion-HPLC MethodPublished: June 28th 2024 | Updated:
Advertisement
Advertisement
Trending on LCGC International
1
Translating Scientific Skills Into Impact: Careers Beyond Research and Academia
2
Advancing Cannabinoid Profiling with UHPLC-MS Chromatography
3
Saying Goodbye to LCGC International
4
Green Stabilizers in Nitrocellulose Propellants: VOC Fingerprinting of Accelerated Aging by HS-SPME–GC×GC–TOF-MS
5